TENOR CAPITAL MANAGEMENT Co., L.P. - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 23 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TENOR CAPITAL MANAGEMENT Co., L.P. ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$5,176,000
+0.1%
5,157,000
-0.2%
0.12%
+6.2%
Q2 2021$5,171,000
-93.2%
5,165,000
-93.1%
0.11%
-94.3%
Q1 2021$76,559,000
+27.7%
74,881,000
+36.4%
1.97%
+17.0%
Q4 2020$59,943,000
+35.2%
54,881,000
+28.9%
1.68%
-0.4%
Q3 2020$44,351,000
+16.5%
42,574,000
+23.6%
1.69%
-1.7%
Q2 2020$38,081,000
+7.7%
34,448,0000.0%1.72%
+0.3%
Q1 2020$35,346,000
-23.0%
34,448,000
-14.2%
1.72%
-38.9%
Q3 2019$45,920,000
-3.8%
40,132,0000.0%2.81%
+16.7%
Q2 2019$47,726,000
-12.4%
40,132,0000.0%2.41%
-25.4%
Q1 2019$54,451,000
+32.6%
40,132,000
+5.2%
3.22%
+19.1%
Q4 2018$41,064,000
+29.3%
38,132,000
+27.0%
2.71%
+42.4%
Q3 2018$31,770,000
+26.2%
30,025,000
+17.3%
1.90%
+26.3%
Q2 2018$25,171,000
+0.6%
25,597,000
+2.0%
1.51%
-4.9%
Q1 2018$25,027,000
-5.9%
25,097,0000.0%1.58%
-21.6%
Q4 2017$26,583,000
+24.7%
25,097,000
+25.5%
2.02%
+21.7%
Q3 2017$21,312,000
+25.2%
20,000,000
+25.0%
1.66%
+6.4%
Q2 2017$17,021,00016,000,0001.56%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2021
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 74,881,000$76,559,0001.97%
III Capital Management 15,000,000$15,227,0001.82%
TFG Asset Management GP Ltd 14,055,000$14,321,0001.02%
MACKAY SHIELDS LLC 28,304,000$28,739,0000.21%
RWC Asset Management LLP 6,500,000$6,604,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 7,187,000$7,281,0000.17%
CQS (US), LLC 4,000,000$4,092,0000.13%
FARALLON CAPITAL MANAGEMENT LLC 24,435,000$24,797,0000.12%
D. E. Shaw & Co., Inc. 59,728,000$60,845,0000.06%
BNP Paribas Asset Management Holding S.A. 7,000,000$7,133,0000.03%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders